Our Team

SPRIG delivers a team, not just a PowerPoint deck. Our extensive healthcare industry experience leverages functional backgrounds in:


Katie Arnold Founder & CEO

SPRIG Consulting, LLC is led by Katie Arnold, a strategic marketing professional with 20 years of healthcare experience. Katie has worked with medical technology companies ranging from venture-backed start-ups to Fortune 500 companies. Throughout her career, Katie has focused on the entire spectrum of marketing needs: from early stage market development strategies to downstream launch execution and commercialization efforts. Prior to founding SPRIG, Katie was an independent marketing consultant working on projects that ranged from business plan refinement & market opportunity assessments to development of marketing strategies that included corporate/product positioning and brand development. Katie has demonstrated an aptitude for delivering flawless launch execution and commercialization strategy implementation in the US, EU and AP geographies. During her tenure, Katie is proud to have named numerous medical companies, products and technologies. Prior to consulting, Katie had a successful career with Guidant Corporation (acquired) and Kensey Nash Corporation (acquired) launching new, novel technologies, such as thrombus management catheters, embolic protection devices, and coronary stents. As Director of Marketing at Kensey Nash, Katie played a key role in establishing the company in the Endovascular space through a strategic corporate branding initiative and numerous product launches. At the end of her tenure, the division was sold to Spectranetics (SPNC). While at Guidant, Katie served as a Senior Global Product Manager where she successfully led the launch of the company’s first cobalt chromium stent for small vessels, the ML MINI VISION™. Katie also held positions in strategic corporate marketing as well as sales. Katie holds an MBA from Northwestern University’s Kellogg Graduate School of Management where she was awarded the Health Industry Management Scholarship for recognition of her leadership in the health industry. Currently, Katie is a Kellogg lecturer and teaches the course medical product commercialization to future healthcare leaders. Prior to business school, Katie spent six years working in health care risk management for the medical malpractice divisions of CNA Insurance Companies and MMI Insurance Company. In her role, Katie worked directly with physicians, hospital administrators, health care systems, and managed care organizations. Katie holds a BA from the University of Vermont.

Carla Benigni Consultant

Carla Benigni brings 15 years of medical device marketing, commercialization, sales strategy consulting and engineering experience to SPRIG consulting. Prior to SPRIG, Carla worked for Boston Scientific, Guidant Corporation and Exactech, where she gained extensive experience in commercialization and product development in the cardiac rhythm management and orthopedic fields. Carla led a successful sales career at Boston Scientific’s Cardiac Rhythm Management division that included launching new products and managing physician and administration customer relationships. Prior to her sales role, Carla was a sales strategy consultant and an internal consultant for Guidant’s Market Development Sales Organization. At Exactech, Carla led physician development teams for new products, including developing the company’s first upper extremity offering. This experience incorporated gathering voice of customer driven specification, engineering product, collecting customer validation, obtaining regulatory approval and launching products. Carla holds a MBA from Northwestern University’s Kellogg School of Management and a Masters of Engineering Management from Northwestern University’s McCormick School of Engineering where she majored in biotechnology, marketing and strategy & management.  She also has a Bachelor of Science in Engineering from Duke University in Mechanical Engineering and Material Science.

Jennifer Fitzgerald Consultant

Jen Fitzgerald is an engineer and marketing professional who brings more than 20 years of experience developing and launching products within the healthcare industry. Prior to SPRIG, Jen worked for Vygon Corporation, Spectranetics, and Kensey Nash Corporation where she developed and marketed products in the fields of urology, vascular access, vascular closure, atherectomy (laser and rotational), thrombus management, embolic protection, enteral feeding, and infection control. Jen has held director-level management positions in marketing and training at established public companies as well as small private start-ups.  At Vygon, Jen played a key role in establishing Vygon’s presence in the US through a series of new product launches and downstream commercialization activities. Prior to Vygon, Jen led the marketing and training departments for Spectranetics where she instituted a strategic corporate branding initiative and launched nation-wide marketing and training programs to support their key product category.  These market development programs allowed the company to realize substantial year-over-year revenue growth for the coronary division.  During her 12 years with Kensey Nash, Jen held numerous engineering and marketing positions.  In these roles, she launched the company’s first two endovascular products and led all aspects of the product development effort for several medical products, including the 6F AngioSeal® Vascular Closure Device.  To date, AngioSeal remains the worldwide market leader in the field of vascular closure. Jen holds a Master of Science degree in Technology Management from PENN Engineering and The Wharton School of Business and a Bachelor of Science degree in Biomedical Engineering from Boston University.

Dan Heilbrunn Consultant

Dan Heilbrunn has nearly two decades of experience in medical device marketing and business development including multiple senior management and board positions at start-up companies. Prior to joining SPRIG Consulting, Dan worked for CeloNova BioSciences, Nexeon MedSystems, and Guidant Corporation where he developed and marketed products in the fields of coronary and peripheral stenting, embolic protection, stroke prevention, intravascular brachytherapy, stem cell injection systems, and carbon nanotube technology. Before entering consulting, Dan was the head of coronary stent marketing for CeloNova where he rebranded the company’s core coating technology, developed new sales training programs, and led the European launch preparation for the next-generation stent platform. Prior to joining CeloNova, Dan was a vice president at Nexeon, a start-up accelerator developing physician invented technologies. In this role, he managed all marketing activities and business development efforts including a successful alliance with a NASDAQ mid-cap company. Dan led the company’s sales strategy including seeking out alliance partners and negotiating distribution agreements. Previously, Dan was Guidant’s lead marketing person for carotid stenting and embolic protection, directing the worldwide commercialization and managing the first-to-market launch of this new therapy in the U.S. Dan’s initial years with Guidant were in Japan where he assisted the company in establishing a direct sales subsidiary for the vascular intervention market. In Japan Dan developed launch strategies for the coronary intervention products and built new teams for the intravascular radiation therapy and neurovascular therapy markets. Dan holds a Master of Business Administration and a Master of Arts in Japan Area Studies from the University of Michigan and a Bachelor of Science in Engineering from Duke University where he majored in electrical engineering and economics. Prior to earning his MBA and entering the medical industry, Dan served as a project leader designing 8-bit and 16-bit microcontrollers for Mitsubishi Semiconductor America.

Charlene Herndon Consultant

Charlene Herndon is a marketing professional with 15 years of experience in strategic marketing, commercial execution and product management within the bioscience and medical device industries. Prior to joining SPRIG, Charlene worked for Cardinal Health, Medtronic, Harvard Bioscience, and Nova Biomedical where she gained experience in upstream product and market development strategies as well as downstream commercialization within the fields of vascular compression, enteral feeding, physiology, surgery and biomaterials. Charlene was a Portfolio Director at Cardinal Health, joining the organization as part of the Patient Recovery divestiture from Medtronic.  In this role, Charlene managed a team that supported both commercial enablement and new product development for their vascular compression business.  With Medtronic, Charlene focused on commercial globalization and market expansion, leading downstream marketing programs and awareness initiatives for their vascular and enteral feeding portfolios. During her years with Harvard Bioscience, Charlene held numerous roles including technical support, capital sales, product management and strategic marketing. She was responsible for the upstream product pipeline, successfully executed numerous global product launches and leading commercialization and training programs within various key product categories. Charlene also gained valuable business development experience, including the integration of several key corporate acquisitions. Charlene holds a Bachelor of Science in Biology from Bucknell University as well as minors in both Spanish and Sociology.

Swarun KulasekaranConsultant

An engineer by training, Swarun is a strategic marketing professional with experience working across multiple fields including Peripheral Vascular, Structural Heart, Cardiac Rhythm Management, Neurovascular, Diabetes, Electrophysiology, and Remote Patient Monitoring. At SPRIG, Swarun brings a range of experiences across many stages of commercial development, providing clients with the guidance to launch, sustain, and grow their business. Prior to SPRIG, Swarun worked for Abbott and Medtronic, where he gained experience in commercialization, R&D, and operations. In his role at Abbott Vascular, Swarun led U.S. commercialization efforts for a market leading vascular closure device, focusing on key product messaging, competitive positioning, conference strategy, and sales tactics. At Abbott Cardiac Rhythm Management (formerly St. Jude Medical), Swarun led the strategic direction, engineering activities, and product management of a new manufacturing line, taking it from initial R&D to FDA approval. Swarun began his career at Medtronic Neurovascular (formerly Covidien), where he led the manufacturing line integration of the Reverse Medical startup acquisition. Swarun holds a BA and MS in Biomedical/Mechanical Engineering from the University of Southern California.

Jodi Lamberti

Jodi is a strategic, versatile marketing professional with a proven ability to help start-up medical device companies build brand identity, grow market awareness, and launch new products. She uses a creative, yet practical approach to develop strong brand and product narratives and comprehensive communication and commercialization strategies. She has successfully led upstream and downstream marketing initiatives for start-ups in the electrophysiology and cardiology space including a corporate rebranding initiative in preparation for an EU commercial release. In addition, she has developed commercialization strategies for global product launches and built international KOL networks to support physician education and voice-of-customer initiatives. Recently, she has overseen product and commercial strategy development of remote patient monitoring solutions in the respiratory care market. Jodi has a BA in English and Communications from Iowa State University.

Joe Lynch

Joe Lynch has held marketing leadership roles at top medical technology companies, including Guidant, Abbott, Omnicell, and VitalConnect. He has enjoyed advancing patient care through leading strategic marketing teams to bolster brands, build winning strategies, and lead commercial execution to achieve strong financial results.  At Guidant, Joe oversaw Vascular Intervention Market Intelligence, including long-range planning, market research, competitive intelligence, and economic strategy. His Vision pricing conjoint work generated a 20% increase in product revenue growth. He helped oversee strategic and portfolio planning producing an industry-leading portfolio and competitive position. As CRM clinical sales representative, Joe supported over 200 surgical implants, trained new sales representatives, and launched the Latitude monitoring system. Additionally, his team managed Xience V launch sales and operations planning delivering 98% same day order availability, market share gains, and a $30M increase in profits. As Vice President, Marketing at Omnicell, Joe oversaw market intelligence, commercial, product, digital and corporate marketing, and customer engagement. Launching dozens of products, his teams helped the company achieve record revenue and profits exceeding board expectations of 15% CAGR. Joe personally supported customer wins with WellStar Health System, Stanford Health, and Partners Healthcare. Omnicell’s Inspired by Care brand won the Marcom platinum award, and its products won 12+ years of KLAS awards, supporting revenue growth of $200M to $700M. Following Omnicell, Joe served as Chief Marketing Officer for venture-backed startup VitalConnect. Working with customers, his team advanced 2.0 patient remote monitoring product requirements to include EHR integration, video conferencing, and early warning score capabilities. Joe implemented Salesforce and established a SaaS model to support a 20% price increase. A passionate career builder and entrepreneur, Joe also founded Wonderbench, a boutique recruiting firm helping companies successfully recruit interns and college graduates. He holds an MBA from The Wharton School, University of Pennsylvania, and a B.S. in Finance from the University of Colorado, Boulder.

Evan Norton
Strategic Advisor

Evan Norton serves as a strategic advisor to SPRIG. As a Managing Partner for Ballast Capital, Evan is on several medtech boards and operates the investment firm, Ballast Capital LLC. Prior to starting Ballast, he was a General Partner at Accelmed Partners. Evan has led over 30 financings and has had 15 of his prior investments either be acquired or become public companies. He previously spent a decade with Abbott Labs leading the corporate venture arm, Abbott Ventures. Prior to Abbott, he was a Principal with ONSET Ventures focused on health tech investing. He has a diverse background of operating experience in the health tech space including the endoscopy, diabetes and ear, nose and throat markets having worked for Stryker Endoscopy, J&J LifeScan and Acclarent.

In addition to his medical device experience, Evan worked for the Investment Banking Group at J.P. Morgan Chase & Co and in the consulting practice at PriceWaterhouseCoopers.

Evan holds an MBA degree from the J.L. Kellogg Graduate School of Management and a BBA cum laude in Finance from Texas A&M University. He currently is an adjunct professor at Kellogg (Medical Products Commercialization and Funding) and serves on the Innovation and New Ventures Advisory Board and N.XT Fund investment committee at Northwestern University. Evan has lectured at numerous business schools including the Coller School at Tel Aviv University and Duke’s Fuqua School.

Rebecca Raabe Consultant

Rebecca Raabe has a diverse background of medical device marketing and venture investing experience working for both public and private medical device companies in various markets including interventional cardiology, orthopedics, aesthetics, and electrophysiology. Prior to SPRIG, Rebecca worked for Abbott Ventures, Ulthera (acquired by Merz), Cayenne Medical, and Abbott Vascular where she gained extensive experience in both upstream product and market development strategies as well as downstream commercialization. At Abbott Ventures, Rebecca helped manage Abbott’s equity investments as well as developed and executed new franchise strategies for the business. Rebecca held a leadership role in the conception and execution of the Abbott electrophysiology strategy, which included acquiring Topera Medical, placing a call option on ACT Medical, and performing detailed analysis on other electrophysiology opportunities. While at Ulthera, Rebecca was responsible for consumer marketing activities including the launch of the company’s national public relations campaign for their nonsurgical skin tightening procedure with placements in Dr. Oz, Rachel Ray, The View, Vogue, Marie Claire and WSJ. At Cayenne Medical, Rebecca successfully led the commercial launch of the company’s third product, a meniscal repair device, as well as managed product development and training program activities. While at Abbott Vascular, Rebecca was responsible for market intelligence activities including competitive assessments, market analysis, commercial modeling, and customer research. Rebecca holds a MBA from Northwestern University’s Kellogg School of Management where she majored in health enterprise management and marketing. She also holds a BA in Biochemical Sciences from Harvard University.

Steve Roller Consultant

Steve Roller brings 15 years of medical device experience in strategy, R&D, program management, and manufacturing to Sprig Consulting.

Prior to Sprig, Steve worked for Medtronic where he had a successful track record of bringing new medical technologies to market. His experiences spanned a variety of product lines including heart valve repair and replacement, perfusion systems for open heart surgery, as well as cardiac rhythm and neurological devices. He also has experience consulting with universities on their tech transfer portfolios and startup companies.

As part of Medtronic, Steve led the design and development of a next generation transcatheter heart valve, taking it from concept selection to FDA approval. He also led a cross functional team in the launch of a mechanical heart valve and was integral in the development and launch of two perfusion systems. Since leaving Medtronic he has consulted with the University of Maryland, Baltimore, evaluating IP from university physicians and providing strategic direction, as well as go-to-market planning for university medical device startups.

Steve holds and MBA from the University of Minnesota Carlson School of Management and has his Master of Science and Engineering from the University of Michigan in Biomedical Engineering. He also holds his Bachelor of Science and Engineering from the University of Michigan in Mechanical Engineering.

Molly Traugott Consultant

Molly Traugott is a healthcare marketing expert with a proven ability to develop and implement high-impact, value-based marketing strategy. Molly comes from a wide variety of marketing experience with early-stage, middle-stage and Fortune 500 medical companies. Her focus includes providing reimbursement and market analytics for all payment pathways, including Medicare. Through comprehensive research and her extensive network, Molly designs individualized strategies for successful medtech product adoption. Molly’s most recent endeavor included teaming up with a provider-focused start-up to successfully transition hospitals and surgeons to value-based care by way of increased surgeon alignment, process redesign, service line analytics and advanced clinical support solutions. At the Neocure Group, a highly specialized medical device reimbursement consulting firm based in Boston, MA, Molly was in charge of the marketing and product launch of the innovative marketing and reimbursement focused data analytics platform, FocusPro™ to position medtech companies for greatest market impact. This lead to the company’s acquisition by Intralign Health, a specialty healthcare company helping providers optimize service line performance through a unique combination of clinical services and operational tools and analytics. As corporate Marketing Director, Molly lead the growth and development of a start-up into an industry-recognized brand. Molly holds a Bachelor of Science in Marketing from the honors program at Providence College.

Our History

SPRIG celebrates 10 years. Founded in 2008 in Silicon Valley in response to the emerging needs of early-stage medical technology start-ups to navigate company development with limited resources and strict financial constraints. Since our inception, we have produced clear, measurable results for an exciting roster of clients – ranging from start-ups to multi-billion dollar organizations. We are honored and proud that our primary referral source has been word of mouth. This is a significant indicator that we are achieving our goals.

Our Experience

With experience across a broad range of therapeutic spaces, SPRIG brings industry knowledge which ensures a quick ramp-up and allows us to add immediate value.